This is the Vocab24 daily quiz of 5 September 2025, the same 30 questions the app served that day, on the day's vocabulary and editorial. One mark for a right answer, minus 0.25 for a wrong one; the explanation opens as soon as you tap.
Out of the given alternatives select the alternative which best expresses the meaning of given word.
Fragile
Out of the given alternatives select the alternative which best expresses the meaning of given word.
Convened
Out of the given alternatives select the alternative which best expresses the meaning of given word.
Divergence
Out of the given alternatives select the alternative which best expresses the meaning of given word.
Speculation
Out of the given alternatives select the word opposite in meaning to the given word.
Sparing
Out of the given alternatives select the word opposite in meaning to the given word.
Impeachment
Out of the given alternatives select the word opposite in meaning to the given word.
Stern
Out of the given alternatives select the word opposite in meaning to the given word.
Defying
Out of given alternatives, choose the word which can be substituted for the given words/ sentence.
To come together or to bring people together for a meeting, etc.
Out of given alternatives, choose the word which can be substituted for the given words/ sentence.
The activity of guessing possible answers to a question without having enough information to be certain
Out of given alternatives, choose the word which can be substituted for the given words/ sentence.
An act of calling into question the integrity or validity of something.
Out of given alternatives, choose the word which can be substituted for the given words/ sentence.
A refusal to obey something or someone.
A statement with one blank is given below. Choose the set of words from the given options which can be used to fill the given blank.
We ____ be visiting him tomorrow.
Explanation: 'shall' is used with future tenses. 'tomorrow' means future tense and therefore 'shall not' is the correct usage.
A statement with one blank is given below. Choose the set of words from the given options which can be used to fill the given blank.
Have ____ love for animals.
Explanation: We use 'a little' with singular uncountable nouns. We use 'a few' with plural countable nouns: <br> Mary said nothing, but she drank some tea and ate a little bread. <br> We stayed a few days in Florence and visited the museums.
A statement with one blank is given below. Choose the set of words from the given options which can be used to fill the given blank.
Asmah ____ a book yesterday.
Explanation: The past tense of 'read' is 'read', spelled the same but pronounced differently - it is pronounced as 'red'. The verb 'read' has an irregular past tense form as it does not accept the addition of '-ed' or '-d'.
Out of given alternatives select the option which best expresses the meaning of given idiom/ phrase.
This matter has been hanging fire for the last many months and must therefore be decided one way or the other.
Explanation: hanging fire: to delay, wait, hold back, or hesitate.
Out of given alternatives select the option which best expresses the meaning of given idiom/ phrase.
In the armed forces, it is considered a great privilege to die in harness.
Explanation: die in harness: to die while still at work.
Out of given alternatives select the option which best expresses the meaning of given idiom/ phrase.
The cricket match proved to be a big draw.
Explanation: big draw: a big source of attraction.
Out of given alternatives select the word which is correctly spelt.
Choose the Correct Spelling.
Out of given alternatives select the word which is correctly spelt.
Choose the Correct Spelling.
Out of given alternatives select the word which is correctly spelt.
Choose the Correct Spelling.
Out of given alternatives select the word which is correctly spelt.
Choose the Correct Spelling.
Which of phrases given below each sentence should replace the phrase printed in bold type to make the grammatically correct? If the sentence is correct as it is, mark 'd' as the answer.
(a) My father/ (b) has left/ (c) for Mumbai last Sunday./ (d) No error.
Explanation: had left
Which of phrases given below each sentence should replace the phrase printed in bold type to make the grammatically correct? If the sentence is correct as it is, mark 'd' as the answer.
(a) Don't think/ (b) you can deceive me/ (c) like you did my brother./ (d) No Error.
Explanation: as you did
Which of phrases given below each sentence should replace the phrase printed in bold type to make the grammatically correct? If the sentence is correct as it is, mark 'd' as the answer.
(a) How I wish it had been me/ (b) whom you had froghtened/ (c) and not my daughter. (d) No error.
Explanation: it had been I
Directions: Read the following passage to answer the given questions based on it. Some words/phrases are printed in bold to help you locate them while answering some of the questions. <br> <br> By February of last year, Victoria Reiter, 63, figured she had only a few months to live. A writer and translator living in Manhattan, she was suffering from chronic myeloid leukemia, an especially deadly form of blood cancer. The only treatment available was interferon, an immune-system booster that wasn't really working and that made her violently ill. Reiter had spent most of 1999 in bed, too such to read, to walk, to do much of anything-although she had managed to put together lists dividing her possessions between her two daughters. <br><br> Then she went on an experimental drug called Gleevec, and within weeks everything changed. "All my energy started coming back," she says. "Suddenly I could read. I could take a walk." By August, tests showed her bone marrow was clear of leukemia cells; in December, she took up the Argentine tango. She still has the lists of what her daughters will get, but, she exults. "They're not going to get it yet!" <br><br> For Bob Ferber, a Los Angeles prosecutor specializing in animal-abuse cases, the Gleevec experience was very much the same. Less than two years ago, he was lying in a hospital room considering suicide to escape the pain radiating from his bones. "From crawling across the floor on my knees to go to the bathroom, I'm now back at work," says Ferber, 48. "I go to the gym. I'm volunteering for an animal-rescue group. It's the dream of any cancer patient in the world to be able to take a pill that works like this. It's truly a miracle." <br><br> That's a tempting way to look at it, anyhow. Gleevec is so effective that the US Food and Drug Administration approved it in record time two weeks ago-even as researchers announced that it also works against a rare form of stomach cancer. The drug doesn't help everyone, and it can have side-effects, including nausea, muscle cramps and skin rash. Moreover, nobody is claiming that it actually cures cancer. Patients may have to continue taking the drug, probably for the rest of their lives, and unless Gleevec is used in combination with some other drugs, it is likely their cancer will come back. <br><br> Despite all these caveats, Gleevec is still a breakthrough-not only for what it does but, more important, for the revolutionary strategy it represents. A full 50 years have passed since the leaders of developed countries declared war on cancer and called for a national commitment comparable to the effort to land on the moon or split the atom. But over decades, researchers have come up with one potential miracle cure after another-only to suffer one disappointment after another. Aside from surgery, which almost invariably leaves behind some malignant cells, the standard treatment for most cancers continues to be radiation and chemotherapy-relatively crude disease-fighting weapons that have limited effectiveness and leave patients weak and nauseated. <br><br> Along the way, though, scientists have amassed a wealth of information about how cancer works at the molecular level, from its first awakening in the aberrant DNA of a single cell's nucleus to its rapacious, all-out assault on the body. Armed with that information, they have been developing a broad array of weapons to attack the disease every step along the way. Many of these therapies are just beginning to reach clinical trails and won't be available to save lives for years to come. If you have cancer today, these treatments are likely to come too late to help you. But, says Dr. Larry Norton, a medical director at Memorial Sloan Kettering Cancer Center inn New York City : "I think there is no question that the war on cancer is winnable." <br><br> The sentiment was pounded home last week at the annual meeting of the American Society of Clinical Oncology in San Francisco, where a record 26,000 cancer specialists from around the world briefed each other on the good news starting to pour out of their laboratories. Unlike chemo and radiation, which use carpetbombing tactics that destroy cancer cells and healthy cells alike, these new medicines are like a troop of snipers, firing on cancer cells alone and targeting their weakest links.
Victoria Reiter came to know her days were numbered because of<br> 1. The immune system booster. <br> 2. Chronic myeloid leukemia. <br> 3. Failure of interferon.
Explanation: Kindly refer to the 2nd and 3rd sentences of the 1st paragraph.
Directions: Read the following passage to answer the given questions based on it. Some words/phrases are printed in bold to help you locate them while answering some of the questions. <br> <br> By February of last year, Victoria Reiter, 63, figured she had only a few months to live. A writer and translator living in Manhattan, she was suffering from chronic myeloid leukemia, an especially deadly form of blood cancer. The only treatment available was interferon, an immune-system booster that wasn't really working and that made her violently ill. Reiter had spent most of 1999 in bed, too such to read, to walk, to do much of anything-although she had managed to put together lists dividing her possessions between her two daughters. <br><br> Then she went on an experimental drug called Gleevec, and within weeks everything changed. "All my energy started coming back," she says. "Suddenly I could read. I could take a walk." By August, tests showed her bone marrow was clear of leukemia cells; in December, she took up the Argentine tango. She still has the lists of what her daughters will get, but, she exults. "They're not going to get it yet!" <br><br> For Bob Ferber, a Los Angeles prosecutor specializing in animal-abuse cases, the Gleevec experience was very much the same. Less than two years ago, he was lying in a hospital room considering suicide to escape the pain radiating from his bones. "From crawling across the floor on my knees to go to the bathroom, I'm now back at work," says Ferber, 48. "I go to the gym. I'm volunteering for an animal-rescue group. It's the dream of any cancer patient in the world to be able to take a pill that works like this. It's truly a miracle." <br><br> That's a tempting way to look at it, anyhow. Gleevec is so effective that the US Food and Drug Administration approved it in record time two weeks ago-even as researchers announced that it also works against a rare form of stomach cancer. The drug doesn't help everyone, and it can have side-effects, including nausea, muscle cramps and skin rash. Moreover, nobody is claiming that it actually cures cancer. Patients may have to continue taking the drug, probably for the rest of their lives, and unless Gleevec is used in combination with some other drugs, it is likely their cancer will come back. <br><br> Despite all these caveats, Gleevec is still a breakthrough-not only for what it does but, more important, for the revolutionary strategy it represents. A full 50 years have passed since the leaders of developed countries declared war on cancer and called for a national commitment comparable to the effort to land on the moon or split the atom. But over decades, researchers have come up with one potential miracle cure after another-only to suffer one disappointment after another. Aside from surgery, which almost invariably leaves behind some malignant cells, the standard treatment for most cancers continues to be radiation and chemotherapy-relatively crude disease-fighting weapons that have limited effectiveness and leave patients weak and nauseated. <br><br> Along the way, though, scientists have amassed a wealth of information about how cancer works at the molecular level, from its first awakening in the aberrant DNA of a single cell's nucleus to its rapacious, all-out assault on the body. Armed with that information, they have been developing a broad array of weapons to attack the disease every step along the way. Many of these therapies are just beginning to reach clinical trails and won't be available to save lives for years to come. If you have cancer today, these treatments are likely to come too late to help you. But, says Dr. Larry Norton, a medical director at Memorial Sloan Kettering Cancer Center inn New York City : "I think there is no question that the war on cancer is winnable." <br><br> The sentiment was pounded home last week at the annual meeting of the American Society of Clinical Oncology in San Francisco, where a record 26,000 cancer specialists from around the world briefed each other on the good news starting to pour out of their laboratories. Unlike chemo and radiation, which use carpetbombing tactics that destroy cancer cells and healthy cells alike, these new medicines are like a troop of snipers, firing on cancer cells alone and targeting their weakest links.
Victoria Reiter had decided to<br> 1. Divide her property between her two daughters owing to her chronic illness. <br> 2. Postpone her plan of dividing her possessions between her two daughters as she had started recovering. <br> 3. Undergo a treatment with an experimental drug called Gleevec when the interferon treatment was found to be futile.
Explanation: In the given context of the passage, only 3rd statement can be inferred from the 1st sentence of the 2nd paragraph. <br>The other 2 statements 1st and 2nd are redundant as Victoria had already managed to divide her property or possessions between her two daughters. <br> The answer, therefore, is option E.
Directions: Read the following passage to answer the given questions based on it. Some words/phrases are printed in bold to help you locate them while answering some of the questions. <br> <br> By February of last year, Victoria Reiter, 63, figured she had only a few months to live. A writer and translator living in Manhattan, she was suffering from chronic myeloid leukemia, an especially deadly form of blood cancer. The only treatment available was interferon, an immune-system booster that wasn't really working and that made her violently ill. Reiter had spent most of 1999 in bed, too such to read, to walk, to do much of anything-although she had managed to put together lists dividing her possessions between her two daughters. <br><br> Then she went on an experimental drug called Gleevec, and within weeks everything changed. "All my energy started coming back," she says. "Suddenly I could read. I could take a walk." By August, tests showed her bone marrow was clear of leukemia cells; in December, she took up the Argentine tango. She still has the lists of what her daughters will get, but, she exults. "They're not going to get it yet!" <br><br> For Bob Ferber, a Los Angeles prosecutor specializing in animal-abuse cases, the Gleevec experience was very much the same. Less than two years ago, he was lying in a hospital room considering suicide to escape the pain radiating from his bones. "From crawling across the floor on my knees to go to the bathroom, I'm now back at work," says Ferber, 48. "I go to the gym. I'm volunteering for an animal-rescue group. It's the dream of any cancer patient in the world to be able to take a pill that works like this. It's truly a miracle." <br><br> That's a tempting way to look at it, anyhow. Gleevec is so effective that the US Food and Drug Administration approved it in record time two weeks ago-even as researchers announced that it also works against a rare form of stomach cancer. The drug doesn't help everyone, and it can have side-effects, including nausea, muscle cramps and skin rash. Moreover, nobody is claiming that it actually cures cancer. Patients may have to continue taking the drug, probably for the rest of their lives, and unless Gleevec is used in combination with some other drugs, it is likely their cancer will come back. <br><br> Despite all these caveats, Gleevec is still a breakthrough-not only for what it does but, more important, for the revolutionary strategy it represents. A full 50 years have passed since the leaders of developed countries declared war on cancer and called for a national commitment comparable to the effort to land on the moon or split the atom. But over decades, researchers have come up with one potential miracle cure after another-only to suffer one disappointment after another. Aside from surgery, which almost invariably leaves behind some malignant cells, the standard treatment for most cancers continues to be radiation and chemotherapy-relatively crude disease-fighting weapons that have limited effectiveness and leave patients weak and nauseated. <br><br> Along the way, though, scientists have amassed a wealth of information about how cancer works at the molecular level, from its first awakening in the aberrant DNA of a single cell's nucleus to its rapacious, all-out assault on the body. Armed with that information, they have been developing a broad array of weapons to attack the disease every step along the way. Many of these therapies are just beginning to reach clinical trails and won't be available to save lives for years to come. If you have cancer today, these treatments are likely to come too late to help you. But, says Dr. Larry Norton, a medical director at Memorial Sloan Kettering Cancer Center inn New York City : "I think there is no question that the war on cancer is winnable." <br><br> The sentiment was pounded home last week at the annual meeting of the American Society of Clinical Oncology in San Francisco, where a record 26,000 cancer specialists from around the world briefed each other on the good news starting to pour out of their laboratories. Unlike chemo and radiation, which use carpetbombing tactics that destroy cancer cells and healthy cells alike, these new medicines are like a troop of snipers, firing on cancer cells alone and targeting their weakest links.
What was the impact of Gleevec on the health of Victoria Reiter?
Explanation: Kindly refer to the 2nd paragraph.
Directions: Read the following passage to answer the given questions based on it. Some words/phrases are printed in bold to help you locate them while answering some of the questions. <br> <br> By February of last year, Victoria Reiter, 63, figured she had only a few months to live. A writer and translator living in Manhattan, she was suffering from chronic myeloid leukemia, an especially deadly form of blood cancer. The only treatment available was interferon, an immune-system booster that wasn't really working and that made her violently ill. Reiter had spent most of 1999 in bed, too such to read, to walk, to do much of anything-although she had managed to put together lists dividing her possessions between her two daughters. <br><br> Then she went on an experimental drug called Gleevec, and within weeks everything changed. "All my energy started coming back," she says. "Suddenly I could read. I could take a walk." By August, tests showed her bone marrow was clear of leukemia cells; in December, she took up the Argentine tango. She still has the lists of what her daughters will get, but, she exults. "They're not going to get it yet!" <br><br> For Bob Ferber, a Los Angeles prosecutor specializing in animal-abuse cases, the Gleevec experience was very much the same. Less than two years ago, he was lying in a hospital room considering suicide to escape the pain radiating from his bones. "From crawling across the floor on my knees to go to the bathroom, I'm now back at work," says Ferber, 48. "I go to the gym. I'm volunteering for an animal-rescue group. It's the dream of any cancer patient in the world to be able to take a pill that works like this. It's truly a miracle." <br><br> That's a tempting way to look at it, anyhow. Gleevec is so effective that the US Food and Drug Administration approved it in record time two weeks ago-even as researchers announced that it also works against a rare form of stomach cancer. The drug doesn't help everyone, and it can have side-effects, including nausea, muscle cramps and skin rash. Moreover, nobody is claiming that it actually cures cancer. Patients may have to continue taking the drug, probably for the rest of their lives, and unless Gleevec is used in combination with some other drugs, it is likely their cancer will come back. <br><br> Despite all these caveats, Gleevec is still a breakthrough-not only for what it does but, more important, for the revolutionary strategy it represents. A full 50 years have passed since the leaders of developed countries declared war on cancer and called for a national commitment comparable to the effort to land on the moon or split the atom. But over decades, researchers have come up with one potential miracle cure after another-only to suffer one disappointment after another. Aside from surgery, which almost invariably leaves behind some malignant cells, the standard treatment for most cancers continues to be radiation and chemotherapy-relatively crude disease-fighting weapons that have limited effectiveness and leave patients weak and nauseated. <br><br> Along the way, though, scientists have amassed a wealth of information about how cancer works at the molecular level, from its first awakening in the aberrant DNA of a single cell's nucleus to its rapacious, all-out assault on the body. Armed with that information, they have been developing a broad array of weapons to attack the disease every step along the way. Many of these therapies are just beginning to reach clinical trails and won't be available to save lives for years to come. If you have cancer today, these treatments are likely to come too late to help you. But, says Dr. Larry Norton, a medical director at Memorial Sloan Kettering Cancer Center inn New York City : "I think there is no question that the war on cancer is winnable." <br><br> The sentiment was pounded home last week at the annual meeting of the American Society of Clinical Oncology in San Francisco, where a record 26,000 cancer specialists from around the world briefed each other on the good news starting to pour out of their laboratories. Unlike chemo and radiation, which use carpetbombing tactics that destroy cancer cells and healthy cells alike, these new medicines are like a troop of snipers, firing on cancer cells alone and targeting their weakest links.
The author has given the example of Bob Ferber in order to
Explanation: In the 3rd paragraph, the author's given the example of Bob Ferber to present another case in which the drug 'Gleevec' had almost miraculous results on its user, and that, hence, presents 'Gleevec' as a wonder drug. The answer, therefore, is option E.
Directions: Read the following passage to answer the given questions based on it. Some words/phrases are printed in bold to help you locate them while answering some of the questions. <br> <br> By February of last year, Victoria Reiter, 63, figured she had only a few months to live. A writer and translator living in Manhattan, she was suffering from chronic myeloid leukemia, an especially deadly form of blood cancer. The only treatment available was interferon, an immune-system booster that wasn't really working and that made her violently ill. Reiter had spent most of 1999 in bed, too such to read, to walk, to do much of anything-although she had managed to put together lists dividing her possessions between her two daughters. <br><br> Then she went on an experimental drug called Gleevec, and within weeks everything changed. "All my energy started coming back," she says. "Suddenly I could read. I could take a walk." By August, tests showed her bone marrow was clear of leukemia cells; in December, she took up the Argentine tango. She still has the lists of what her daughters will get, but, she exults. "They're not going to get it yet!" <br><br> For Bob Ferber, a Los Angeles prosecutor specializing in animal-abuse cases, the Gleevec experience was very much the same. Less than two years ago, he was lying in a hospital room considering suicide to escape the pain radiating from his bones. "From crawling across the floor on my knees to go to the bathroom, I'm now back at work," says Ferber, 48. "I go to the gym. I'm volunteering for an animal-rescue group. It's the dream of any cancer patient in the world to be able to take a pill that works like this. It's truly a miracle." <br><br> That's a tempting way to look at it, anyhow. Gleevec is so effective that the US Food and Drug Administration approved it in record time two weeks ago-even as researchers announced that it also works against a rare form of stomach cancer. The drug doesn't help everyone, and it can have side-effects, including nausea, muscle cramps and skin rash. Moreover, nobody is claiming that it actually cures cancer. Patients may have to continue taking the drug, probably for the rest of their lives, and unless Gleevec is used in combination with some other drugs, it is likely their cancer will come back. <br><br> Despite all these caveats, Gleevec is still a breakthrough-not only for what it does but, more important, for the revolutionary strategy it represents. A full 50 years have passed since the leaders of developed countries declared war on cancer and called for a national commitment comparable to the effort to land on the moon or split the atom. But over decades, researchers have come up with one potential miracle cure after another-only to suffer one disappointment after another. Aside from surgery, which almost invariably leaves behind some malignant cells, the standard treatment for most cancers continues to be radiation and chemotherapy-relatively crude disease-fighting weapons that have limited effectiveness and leave patients weak and nauseated. <br><br> Along the way, though, scientists have amassed a wealth of information about how cancer works at the molecular level, from its first awakening in the aberrant DNA of a single cell's nucleus to its rapacious, all-out assault on the body. Armed with that information, they have been developing a broad array of weapons to attack the disease every step along the way. Many of these therapies are just beginning to reach clinical trails and won't be available to save lives for years to come. If you have cancer today, these treatments are likely to come too late to help you. But, says Dr. Larry Norton, a medical director at Memorial Sloan Kettering Cancer Center inn New York City : "I think there is no question that the war on cancer is winnable." <br><br> The sentiment was pounded home last week at the annual meeting of the American Society of Clinical Oncology in San Francisco, where a record 26,000 cancer specialists from around the world briefed each other on the good news starting to pour out of their laboratories. Unlike chemo and radiation, which use carpetbombing tactics that destroy cancer cells and healthy cells alike, these new medicines are like a troop of snipers, firing on cancer cells alone and targeting their weakest links.
What, according to Ferber, does a cancer patient look forward to?
Explanation: Kindly refer to the last sentence of the 3rd paragraph.
One Prime for the website and the app, same login. Videos play in the app.
30 questions in 15 minutes, All India rank, streak and explanations. Free: play it here after logging in, or in the app.
Free. Mobile number + OTP, no password.
